New to Bioss? Enjoy 35% of your first order. Use code "FirstOrder35" - Offer valid for new U.S. Customers on direct orders only

CC-930

Overview
Catalog # bs-6544c-2mg-solid
Product Name CC-930
Specifications
Storage Buffer Powder
Storage Condition Store in dry, dark place at -20C for 1 year.
Target
Product Information Molecular Weight: 448.44

Formula: C21 H23 F3 N6 O2

CAS Number: 899805-25-5

InChi Key: IBGLGMOPHJQDJB-MOKVOYLWSA-N

InChi: InChI=1S/C21H23F3N6O2/c22-11-7-15(23)18(16(24)8-11)28-21-27-17-9-25-20(26-12-1-3-14(31)4-2-12)29-19(17)30(21)13-5-6-32-10-13/h7-9,12-14,31H,1-6,10H2,(H,27,28)(H,25,26,29)/t12?,13-,14?/m0/s1

Smiles: OC1CCC(CC1)NC1N=C2C(=CN=1)N=C(NC1C(F)=CC(F)=CC=1F)N2[C@@H]1COCC1

Purity: 98.0

Solubility: DMSO: 89 mg/mLwarmed(183.54 mM). Water: 4 mg/mLwarmed(8.24 mM).

Appearance: Solid Power

Shelf Life: 1.0 years
Description CC-930, also known as Tanzisertib, is a potent, selective, and orally active JNK inhibitor with potential antifibrotic activity. CC-930 entered Phase I clinical trials. Tanzisertib may have potential use for prevention and treatment of dermal fibrosis. Selective inhibition of JNK by CC-930 exerted potent antifibrotic effects in vitro and in different models in vivo. JNK might thus be a novel molecular target for the treatment of fibrosis in SSc.